Dr. Richard Saul wrote a book called "ADHD Does Not Exist." Saul is certain attention ADHD, or attention deficit hyperactivity disorder exists only in its symptoms. The condition does not exist.» Read More
A drug company worker accusing his employer of encouraging excessive dosage in heartburn medications faces a last-ditch U.S. Supreme Court bid.
Ranbaxy Laboratories issued a recall of generic versions of the cholesterol drug Lipitor in the U.S. because of potential dosage issues, WSJ reported.
Pfizer is in clinical trials to create an over-the-counter version of cholesterol drug, Lipitor. Barbara Ryan, FTI Consulting, discusses challenges the pharmaceutical will face.
The Supreme Court will hear an appeal filed by Omnicare in a securities case filed by investors.
The CEO of Sanofi admitted the pharmaceutical giant underperformed in emerging markets last year, after reporting a decline in quarterly sales.
The U.S.'s entire healthcare system needs to change, said Stefano Pessina, the non-executive director of Walgreens.
As Bristol-Myers Squibb prepares to report its Q4 earnings on Friday, CNBC's Morgan Brennan and Seamus Fernandez, Leerink Partners managing director & pharma analyst, discuss if now is the time to invest in the biotech.
Shares in DSM slid on Tuesday, as the head of the Dutch food and chemicals group warned of unfavorable foreign exchange rates, and ruled out any large-scale acquisitions in 2014.
To stop overusing antibiotics in animals, an economist has proposed a fee for using the drugs. But the farm community is pushing back.
Mark Schoenebaum, ISI Group analyst, breaks down the red hot biotech sector and explains why Gilead Sciences is his best play.
Omar Ishrak, Medtronic CEO, discusses implantable devices and opportunities in the U.S as well emerging markets.
Biotech company Aegerion is in hot water with an FDA warning and a Justice Department subpoena over sales and marketing of cholesterol drug Juxtapid.
The pharmaceutical giant Pfizer has struck a deal to test whether Project:EVO, which runs on iPhones and iPads, can discern cognitive differences in healthy older adults at risk of developing Alzheimer's disease.
Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.
Dietary supplements account for nearly 20 percent of drug-related liver injuries that turn up in hospitals, up from 7 percent a decade ago.
Merck issued a voluntary recall of lot of its Gardasil vaccines Friday due to the risk that some of the viles may contain glass particles.
Cubist Pharmaceuticals is focused on treatments for fighting superbugs, an area many drug developers are avoiding. But its success may attract their attention.
The Food and Drug Administration is phasing out the use of antibiotics in meat over concerns about antibiotic-resistant bacteria.
An over-the-counter, FDA-approved treatment for "PE"—premature ejaculation—is beginning clinical trials at Kaiser in Southern California.